Mirabegron Tablet, Film Coated, Extended Release
Product Images NDC 69238-2860

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Mirabegron (NDC 69238-2860). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Ny Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Structure (Mirabegron Extended Release Tablets 1)

FDA Label Image

25mg 90ct Label (Mirabegron Extended Release Tablets 10)

This text provides information about a medication called Mirabegron in tablet form, with each tablet containing 25 mg of the active ingredient. The usual dosage is once daily by mouth. The storage instructions recommend keeping the tablets at a temperature between 20°C to 25°C (68 to 77°F), with excursions permitted within a certain range. The text also includes details about the manufacturer and mentions that the medication should be dispensed in a tight, light-resistant container as defined in the USP.*

FDA Label Image

50mg 90ct Label (Mirabegron Extended Release Tablets 11)

This text provides information on a medication called mirabegron, where each tablet contains 50 mg of the active ingredient. The usual dosage is once daily by mouth. It also gives instructions on storage temperature, advising to keep the tablets between 20°C to 25°C. It mentions that the tablets should be swallowed whole, not crushed or chewed. Additionally, it identifies the manufacturer as Amneal Pharmaceuticals LLC and includes a prescription label indicating "Rx only."*

FDA Label Image

Figure 1 (Mirabegron Extended Release Tablets 2)

FDA Label Image

Figure 2 (Mirabegron Extended Release Tablets 3)

FDA Label Image

Figure 3 (Mirabegron Extended Release Tablets 4)

FDA Label Image

Figure 4 (Mirabegron Extended Release Tablets 5)

FDA Label Image

Figure 5 (Mirabegron Extended Release Tablets 6)

FDA Label Image

Figure 6 (Mirabegron Extended Release Tablets 7)

FDA Label Image

Figure 7 (Mirabegron Extended Release Tablets 8)

FDA Label Image

Figure 8 (Mirabegron Extended Release Tablets 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.